PMID: 2897304Dec 1, 1987Paper

Comparison of pharmacokinetic properties of beta-adrenoceptor blocking drugs

European Heart Journal
D G McDevitt


Beta-adrenoceptor blocking drugs can be characterised by their pharmacokinetic properties. One of the most important factors appears to be lipid solubility. Lipophilic beta-adrenoceptor antagonists, such as propranolol, oxprenolol and metoprolol, are cleared by the liver and undergo hepatic 'first-pass' metabolism. This results in low bioavailability, substantial interpatient variability in 'steady-state' plasma drug concentrations, rapid elimination half-lives and the possibility of drug interactions with other drugs such as pentobarbitone and cimetidine which affect hepatic enzymes. In addition, lipid soluble drugs are distributed widely within the body and penetrate the brain easily and rapidly. This may result in centrally mediated adverse effects such as vivid dreams. In contrast, the more water-soluble beta-adrenoceptor blocking drugs, such as atenolol, sotalol and nadolol, are cleared by the kidney unchanged. They show less interpatient variation in plasma levels, have longer elimination half-lives and do not interact with drugs affecting hepatic enzymes. They penetrate the central nervous system less easily and cause less central side-effect. Between these two extremes, there are several drugs like betaxolol, bisoprolol...Continue Reading


Jan 1, 1990·Journal of the American Academy of Child and Adolescent Psychiatry·D R DeMaso, T A Hunter
Aug 28, 2010·Genes, Brain, and Behavior·L CoutellierT B Usdin
May 3, 2005·Biological & Pharmaceutical Bulletin·Masato TaguchiYukiya Hashimoto
Nov 14, 2007·American Journal of Pharmaceutical Education·Stephen T O'Rourke
Jan 21, 2012·Advanced Drug Delivery Reviews·Fabio BroccatelliLeslie Z Benet
Oct 19, 2006·Progress in Cardiovascular Diseases·Gurusher S Panjrath, Franz H Messerli
Jan 28, 2012·Cardiovascular Therapeutics·Dennis LadageKlara Brixius
Jul 30, 2004·Journal of Chromatography. B, Analytical Technologies in the Biomedical and Life Sciences·Jim FangJiuxue Song
Jul 21, 2012·Drug Metabolism and Pharmacokinetics·Chia-Hsien ChangLi-Jen Lin
Jan 5, 2011·European Neuropsychopharmacology : the Journal of the European College of Neuropsychopharmacology·Hagit CohenJoseph Zohar
Apr 18, 2015·Journal of Burn Care & Research : Official Publication of the American Burn Association·David A BrownNicole S Gibran
May 16, 2017·Bioanalysis·Michael Gröschl
Oct 13, 2018·Movement Disorders : Official Journal of the Movement Disorder Society·Naomi GronichWalid Saliba
Feb 28, 2020·Chirality·Vinod Kumar Vashistha, Anuj Kumar
Dec 25, 2018·Expert Opinion on Drug Metabolism & Toxicology·Christian HöchtAriel H Polizio
Jan 6, 1995·Journal of Chromatography. B, Biomedical Applications·K M HöldR A Maes

Related Concepts

Related Feeds

Cardiology Journals

Discover the latest cardiology research in this collection of the top cardiology journals.

Adrenergic Receptors: Trafficking

Adrenergic receptor trafficking is an active physiological process where adrenergic receptors are relocated from one region of the cell to another or from one type of cell to another. Discover the latest research on adrenergic receptor trafficking here.

Related Papers

American Journal of Therapeutics
John C SombergJanos Molnar
The Consultant Pharmacist : the Journal of the American Society of Consultant Pharmacists
Guido R Zanni, Jeannette Y Wick
Clinical Nutrition : Official Journal of the European Society of Parenteral and Enteral Nutrition
Sofie StaelensGigi Veereman-Wauters
© 2021 Meta ULC. All rights reserved